DEERFIELD, Ill.-- (BUSINESS WIRE)--TerSera Therapeutics LLC announced today that The National Comprehensive Cancer Network® (NCCN) Breast Cancer Panel included both goserelin 3.6 mg every 4 weeks and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results